Neurology India · 2016 · 11 citations · 12 references
MedicineGeneticsMolecular GeneticsIntellectual DisabilitiesMolecular DiagnosticsPrenatal DiagnosisGenetic DisordersGenetic SyndromesIntellectual Disability GeneticsNeurodevelopmental DisordersPrenatal Genetic DiagnosisPrenatal Molecular TestingMolecular Genetic DiagnosisMolecular Prenatal DiagnosisPolymerase Chain Reaction (Pcr)-based DiagnosisPolymerase Chain Reaction-based Prenatal DiagnosisPolymerase Chain Reaction-based ScreeningPremature Ovarian FailurePrenatal Molecular DiagnosisTriplet Repeat Expansion Testing
BACKGROUND: Fragile X syndrome (FXS) is also a leading cause of intellectual disability along with Down's syndrome. It is caused by the expansion of CGG triplet repeat at 5' untranslated region of the fragile X mental retardation 1 (FMR1) gene. Since the prevalence rate is quite high in the general population, molecular diagnosis is important to establish the cause and the prenatal diagnosis. At present, there are a number of methods available with their own merits and demerits. AIM AND METHODS: Molecular screening of intellectually disabled patients and those with premature ovarian failure with combined triplet repeat primed polymerase chain reaction (TP-PCR) and methylation-specific polymerase chain reaction (MS-PCR) for establishing the diagnosis of FXS. RESULTS: The specificity of the method has been validated with archived previously genotyped samples, facilitating the application of this method in the screening procedure. The combined TP-PCR and MS-PCR approach identified six (10%) of the intellectually disabled cases as full mutation positive, one (4%) of the premature ovarian failure cases as premutation positive, and one (out of two) of the prenatal samples as premutation positive. CONCLUSION: The present study concludes that a combined usage of TP-PCR and MS-PCR will be a useful alternative approach to diagnose patients suffering from fragile X syndrome.
12
Absence of expression of the FMR-1 gene in fragile X syndrome
Maura Pieretti, Ying‐Hui Fu, Stephen T. Warren et al. · Cell · 1991 · 1.5K citations
Prevalence of fragile X syndrome
Gillian Turner, T. Webb, Shannon Wake et al. · American Journal of Medical Genetics · 1996 · 698 citations